Drug Discovery

Showing 31-40 of 47

A detailed assessment of emerging technology developments in the field of drug discovery technologies

USD 3,950.00

USD 2,962.50 save 25 %

This Research Service analyzes the emerging trends and technologies in the United States drug discovery industry. It provides a 30,000 foot view of the trends and near term forecasts in these areas while exploring the role these technologies may play in the future.

USD 1,450.00

USD 1,087.50 save 25 %

This issue profiles utilizing platelet-rich plasma as a nuclear cell differentiation technology platform, increasing reprogramming efficiency of induced pluripotent stem cells, and a drug for autoimmune uveitis that receives orphan drug designation in Europe.

USD 950.00

USD 712.50 save 25 %

This issue profiles a vaccine treatment for meningococcal disease that obtains FDA clearance, a nasal testosterone replacement therapy to treat male hypogonadism, and an injection therapy to control hypocalcemia in patients with hypoparathyroidism.

USD 950.00

USD 712.50 save 25 %

This issue profiles understanding genes and pathways to optimize drug development, an intralumenal device for transmucosal drug delivery , and next generation protein-based medicines to treat immunological disorders.

USD 950.00

USD 712.50 save 25 %

This issue profiles a novel drug to treat bile acid synthesis disorders, FDA approval for a drug for treatment of thyroid cancer, and a drug screening technology platform based on modulation of integrin activity.

USD 950.00

USD 712.50 save 25 %

This issue profiles a novel drug developed for treatment of insomnia, a drug for treating swimmer’s ear receives that FDA approval, and development of an advanced drug for chronic weight management.

USD 950.00

USD 712.50 save 25 %

This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.

USD 950.00

USD 712.50 save 25 %

This issue profiles miotoxicity and drug screening assays through micropatterning techniques, leveraging glycobioengineering for cancer research, and pharmacological chaperones to enhance enzyme replacement therapies.

USD 950.00

USD 712.50 save 25 %

This issue depicts the current landscape and the new trends in a series of developments associated with drug discovery and development, including manufacturing for optimal drug delivery, across cancer research, autoimmune diseases, and rare disorders. The technologies incorporated in this study are related to cancer stem cells for cancer therapeuti...

USD 950.00

USD 712.50 save 25 %

Showing 31-40 of 47